Loading...
Insmed Incorporated
INSM•NASDAQ
HealthcareMedical - Pharmaceuticals
$73.60
$0.86(1.18%)
Insmed Incorporated (INSM) Financial Performance & Statements
Review Insmed Incorporated’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
19.17%
↑ 19.17%
Operating Income Growth
-23.76%
↓ 23.76%
Net Income Growth
-21.91%
↓ 21.91%
Operating Cash Flow Growth
-27.53%
↓ 27.53%
Operating Margin
-230.21%
↓ 230.21%
Gross Margin
76.16%
↑ 76.16%
Net Profit Margin
-265.93%
↓ 265.93%
ROE
-446.98%
↓ 446.98%
ROIC
-56.10%
↓ 56.10%
Insmed Incorporated (INSM) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Insmed Incorporated stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $104.44M | $93.42M | $90.34M | $75.50M |
| Cost of Revenue | $26.15M | $21.17M | $22.23M | $18.72M |
| Gross Profit | $78.29M | $72.25M | $68.11M | $56.78M |
| Gross Profit Ratio | $0.75 | $0.77 | $0.75 | $0.75 |
| R&D Expenses | $179.73M | $150.81M | $146.75M | $121.08M |
| SG&A Expenses | $142.51M | $118.93M | $106.57M | $93.10M |
| Operating Expenses | $322.24M | $285.68M | $253.32M | $214.19M |
| Total Costs & Expenses | $348.39M | $306.85M | $275.54M | $232.91M |
| Interest Income | $0.00 | -$720000.00 | $710000.00 | $754000.00 |
| Interest Expense | $21.55M | $20.33M | $20.18M | $19.95M |
| Depreciation & Amortization | $2.74M | $2.72M | $2.70M | $2.85M |
| EBITDA | -$209.99M | -$196.56M | -$275.81M | -$132.61M |
| EBITDA Ratio | -$2.01 | -$2.10 | -$3.05 | -$1.76 |
| Operating Income | -$230.41M | -$213.43M | -$185.20M | -$157.41M |
| Operating Income Ratio | -$2.21 | -$2.28 | -$2.05 | -$2.08 |
| Other Income/Expenses (Net) | -$3.87M | -$6.08M | -$114.57M | $903000.00 |
| Income Before Tax | -$234.28M | -$219.51M | -$299.77M | -$156.50M |
| Income Before Tax Ratio | -$2.24 | -$2.35 | -$3.32 | -$2.07 |
| Income Tax Expense | $1.27M | $1.01M | $838000.00 | $589000.00 |
| Net Income | -$235.55M | -$220.52M | -$300.61M | -$157.09M |
| Net Income Ratio | -$2.26 | -$2.36 | -$3.33 | -$2.08 |
| EPS | -$1.32 | -$1.27 | -$1.94 | -$1.06 |
| Diluted EPS | -$1.32 | -$1.27 | -$1.94 | -$1.06 |
| Weighted Avg Shares Outstanding | $179.02M | $173.72M | $154.70M | $148.46M |
| Weighted Avg Shares Outstanding (Diluted) | $179.02M | $173.72M | $154.70M | $148.46M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan